Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure

Registry ID

EUCTR2012-005592-13

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

King's College London

Start date

2014-02-27

Completion date

2016-12-20

Last update

2026-08-16

Conditions

• Chronic Heart Failure

Summary

To evaluate the effect of iv iron repletion on skeletal muscle oxidative capacity as quantified by PCr t1/2 and ADP t1/2 following gastrocnemius muscle exercise using 31-P MRS.

Locations

• , , UK

Related clinical trials

• The HEARTFELT Study
• A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
• The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
• Mobile-Based Telemedicine and Health-Related Quality of Life Among Patients With Chronic Heart Failure (MOBILE-HF)

View on source registry